Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Finasteride temporarily lowers male rat fertility without affecting libido.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Both drugs lower DHT levels, with GI198745 being more effective.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Finasteride may affect PNMT, causing side effects.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

New compounds may help treat prostate cancer by reducing cell growth.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride exposure harms tadpole reproduction and hormone balance.

Certain Dibenzo derivatives may help treat prostate cancer.

The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Agmatine may help reduce seizures linked to hormone changes in female rats.